Cancer survivors’ experiences of Cardiotoxicity induced Heart Failure: Living in the In-between
May 23, 2025 from 1:40pm EST to 2:35pm EST
Cancer treatment methods, particularly chemotherapy and radiation, have significantly increased survival rates. However, chemotherapy has a detrimental impact on survivors’ heart health, leading to cardiotoxicity-induced heart failure (CIHF). CIHF post-chemotherapy is a life-threatening condition that impairs survivors' quality of life. Cardiotoxicity occurs in 25% of individuals with cancer. CIHF severity depends on an individual’s level of pre-existing risk factors and the chemotherapeutic medications used. There is limited research about how individuals with CIHF cope. This qualitative study explored coping strategies employed by cancer survivors living with CIHF. Semi-structured interviews were conducted with seven individuals (5 females; 2 males; age ranged between 25-70) who developed CIHF after chemotherapy for various cancers. Using interpretive description, guided by the transactional theory of stress and coping, thematic analysis generated the overarching theme of Living in the In-Between. Participants experienced tensions transitioning from surviving cancer to living with CIHF. Sub-themes highlighted the disruptive impact of CIHF symptoms on survivors’ lives and the need to form a new identity post-diagnosis. Coping strategies identified were seeking social supports, making lifestyle changes, and use of positive thinking to live within their new identity. This study identified significant implications for CIHF-related healthcare. Patient, health care professional and public education on the cardiotoxic risks of chemotherapy, the incidence and prevalence, and symptoms of CIHF are needed. Cardiovascular nurses are in a pivotal position to advocate for and educate patients with CIHF how to recognize, manage and cope with symptoms associated with CIHF.